Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'COMPLEX VENTRICULAR ARRHYTHMIAS' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 46 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Tresch, DD
      Evaluation and management of cardiac arrhythmias in the elderly

      MEDICAL CLINICS OF NORTH AMERICA
    2. Aronow, WS
      Beta-blockers, angiotensin-converting enzyme inhibitors, and calcium antagonists in treatment of elderly patients with acute myocardial infarction

      CORONARY ARTERY DISEASE
    3. Naccarelli, GV; Wolbrette, DL; Patel, HM; Luck, JC
      Amiodarone: clinical trials

      CURRENT OPINION IN CARDIOLOGY
    4. Cice, G; Tagliamonte, E; Ferrara, L; Iacono, A
      Efficacy of carvedilol on complex ventricular arrhythmias in dilated cardiomyopathy: double-blind, randomized, placebo-controlled study

      EUROPEAN HEART JOURNAL
    5. Yap, YG; Camm, AJ
      Lessons from antiarrhythmic trials involving class III antiarrhythmic drugs

      AMERICAN JOURNAL OF CARDIOLOGY
    6. Aronow, WS
      Management of the older person with atrial fibrillation

      JOURNAL OF THE AMERICAN GERIATRICS SOCIETY
    7. Kelly, RA; Antman, EM
      Pharmacological therapy of cardiac arrhythmias

      JOURNAL OF THROMBOSIS AND THROMBOLYSIS
    8. CHUNG MK; SCHWEIKERT RA; WILKOFF BL; NIEBAUER MJ; PINSKI SL; TROHMAN RG; KIDWELL GA; JAEGER FJ; MORANT VA; MILLER DP; TCHOU PJ
      IS HOSPITAL ADMISSION FOR INITIATION OF ANTIARRHYTHMIC THERAPY WITH SOTALOL FOR ATRIAL ARRHYTHMIAS REQUIRED - YIELD OF IN-HOSPITAL MONITORING AND PREDICTION OF RISK FOR SIGNIFICANT ARRHYTHMIA COMPLICATIONS

      Journal of the American College of Cardiology
    9. NOLAN PE; NAPPI J; POLLAK PT
      CLINICAL EFFICACY OF AMIODARONE

      Pharmacotherapy
    10. CAMM AJ; HOFFMAN BF; JANSE MJ; KLEBER A; ROSEN MR; SCHWARTZ PJ; ANDERSON JL; BREITHARDT G; CAMPBELL RWF; HALLSTROM AP; HIRAOKA M; MYERBURG RJ; OGAWA S; PRATT CM; RODEN DM; RUSKIN JN; SPOONER PM; TEMPLE RJ; WALDO AL; WOOD AJJ; ZAZA A; BOYDEN P; LAZZARA R
      THE SEARCH FOR NOVEL ANTIARRHYTHMIC STRATEGIES

      European heart journal
    11. PRITCHETT ELC
      EVOLUTION AND REVOLUTION IN DRUG LABELING - REGULATION OF ANTIARRHYTHMIC DRUGS BY THE FOOD-AND-DRUG-ADMINISTRATION 1962-1996

      PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY
    12. ARONOW WS
      MANAGEMENT OF OLDER PERSONS AFTER MYOCARDIAL-INFARCTION

      Journal of the American Geriatrics Society
    13. ARONOW WS
      POSTINFARCTION USE OF BETA-BLOCKERS IN ELDERLY PATIENTS

      Drugs & aging
    14. VANGELDER IC; BRUGEMANN J; CRIJNS HJGM
      PHARMACOLOGICAL MANAGEMENT OF ARRHYTHMIAS IN THE ELDERLY

      Drugs & aging
    15. NAIR LA; GRANT AO
      EMERGING CLASS-III ANTIARRHYTHMIC AGENTS - MECHANISM OF ACTION AND PROARRHYTHMIC POTENTIAL

      Cardiovascular drugs and therapy
    16. CONNOLLY SJ; CAIRNS J; GENT M; ROBERTS R; YUSUF S; JULIAN DG; CAMM AJ; FRANGIN G; JANSE MJ; MUNOZ A; SCHWARTZ PJ; SIMON P; ROSENBAUM MB; ELIZARI MV; CAGIDE A; GIROTTI LA; MARTINEZ JM; CARBAJALES J; SCAPIN O; GARGUICHEVICH J; HAUAD S; BELZITI C; SINISI A; CEREMUZYNSKI L; BUDAJ A; KLECZAR E; NARTOWICZ E; SMIELAKKOROMBEL J; DYDUSZYNSKI A; MACIEJEWICZ J; KOKOWICZ P; NAVARROLOPEZ F; COSIN J; MARRUGAT J; GUINDO J; DELUNA AB; PFISTERER M; OSSWALD S; BURCKHARDT D; BURKART F; HOCKINGS B; GEORGE T; MAHROUS F; TAYLOR R; HAJAR H; SINGH S; FLETCHER R; FISHER S; SINGH B; DOVAL H; NUL D; GRANCELLI H; PERRONE S; BORTMAN G; CURIEL R; RAMOS J; GAMBARTE A; GENTILE A; SIRENA J; TIBALDI M; TOPLIKAR J; NICKLAS J; MCKENNA W; STEWART R; MICKELSON J; DAS S; SCHORK A; KRICKLER S; QUAIN L; MORADY F; PITT B; HAMER A; ARKLES L; JOHNS J; MORRISON L; ROBERTS J
      EFFECT OF PROPHYLACTIC AMIODARONE ON MORTALITY AFTER ACUTE MYOCARDIAL-INFARCTION AND IN CONGESTIVE-HEART-FAILURE - METAANALYSIS OF INDIVIDUAL DATA FROM 6500 PATIENTS IN RANDOMIZED TRIALS

      Lancet
    17. SIM I; MCDONALD KM; LAVORI PW; NORBUTAS CM; HLATKY MA
      QUANTITATIVE OVERVIEW OF RANDOMIZED TRIALS OF AMIODARONE TO PREVENT SUDDEN CARDIAC DEATH

      Circulation
    18. CAMPBELL TJ
      THE PLACE OF AMIODARONE - AN OVERVIEW OF THE 4 RECENT LARGE CONTROLLED TRIALS

      Australian and New Zealand Journal of Medicine
    19. ATLEE JL
      PERIOPERATIVE CARDIAC DYSRHYTHMIAS - DIAGNOSIS AND MANAGEMENT

      Anesthesiology
    20. CAMPBELL RWF
      ACE-INHIBITORS AND ARRHYTHMIAS

      HEART
    21. BUDAJ A; KOKOWICZ P; SMIELAKKOROMBEL W; KUCH J; KRZEMINSKAPAKULA M; MACIEJEWICZ J; NARTOWICZ E; ZALESKA T; DYDUSZYNSKI A; CEREMUZYNSKI L
      LACK OF EFFECT OF AMIODARONE ON SURVIVAL AFTER EXTENSIVE INFARCTION

      Coronary artery disease
    22. TRESCH DD; ARONOW WS
      CLINICAL MANIFESTATIONS AND DIAGNOSIS OF CORONARY-ARTERY DISEASE

      Clinics in geriatric medicine
    23. ANDERSON JL
      POSTMYOCARDIAL INFARCTION TRIALS - BETA-BLOCKERS, ANTIARRHYTHMICS, THROMBOLYTICS

      Controlled clinical trials
    24. REEDER GS; GERSH BJ
      MODERN MANAGEMENT OF ACUTE MYOCARDIAL-INFARCTION

      Current problems in cardiology
    25. NOLL G; KAUFMANN U; WENZEL RR; LUSCHER TF
      MANAGEMENT OF ACUTE MYOCARDIAL-INFARCTION - DIFFERENTIAL USE OF PTCA,SURGERY AND MEDICAL THERAPY

      Schweizerische medizinische Wochenschrift
    26. SINGH BN
      ANTIARRHYTHMIC ACTIONS OF AMIODARONE - A PROFILE OF A PARADOXICAL AGENT

      The American journal of cardiology
    27. FRISHMAN WH; HEIMAN M; KARPENOS A; OOI WL; MITZNER A; GOLDKORN R; GREENBERG S
      24-HOUR AMBULATORY ELECTROCARDIOGRAPHY IN ELDERLY SUBJECTS - PREVALENCE OF VARIOUS ARRHYTHMIAS AND PROGNOSTIC IMPLICATIONS (REPORT FROM THEBRONX LONGITUDINAL AGING STUDY)

      The American heart journal
    28. ARONOW WS
      PREVALENCE OF USE OF BETA-BLOCKERS AND OF CALCIUM-CHANNEL BLOCKERS INOLDER PATIENTS WITH PRIOR MYOCARDIAL-INFARCTION AT THE TIME OF ADMISSION TO A NURSING-HOME

      Journal of the American Geriatrics Society
    29. SINGH BN
      EXPANDING INDICATIONS FOR THE USE OF CLASS-III AGENTS IN PATIENTS AT HIGH-RISK FOR SUDDEN-DEATH

      Journal of cardiovascular electrophysiology
    30. BURKART F
      RATIONALE FOR CURRENT DRUG-TREATMENT

      European heart journal
    31. MANNING A; THISSE V; HODEIGE D; RICHARD J; HEYNDRICKX JP; CHATELAIN P
      SR-33589, A NEW AMIODARONE-LIKE ANTIARRHYTHMIC AGENT - ELECTROPHYSIOLOGICAL EFFECTS IN ANESTHETIZED DOGS

      Journal of cardiovascular pharmacology
    32. BREITHARDT G
      AMIODARONE IN PATIENTS WITH HEART-FAILURE

      The New England journal of medicine
    33. HAGELUKEN A; NURNBERG B; HARHAMMER R; GRUNBAUM L; SCHUNACK W; SEIFERT R
      THE CLASS-III ANTIARRHYTHMIC DRUG AMIODARONE DIRECTLY ACTIVATES PERTUSSIS-TOXIN-SENSITIVE G-PROTEINS

      Molecular pharmacology
    34. JESPERSEN C
      POSTINFARCTION, MYOCARDIAL-ISCHEMIA - CLI NICAL-SIGNIFICANCE AND RELATION TO OTHER RISK MARKERS

      Archives des maladies du coeur et des vaisseaux
    35. TRESCH DD
      DIAGNOSTIC AND PROGNOSTIC VALUE OF AMBULATORY ELECTROGRAPHIC MONITORING IN OLDER PATIENTS

      Journal of the American Geriatrics Society
    36. KIM CH; DAUBERT JP; AKIYAMA T
      ANTIARRHYTHMIC AGENTS IN OLDER PATIENTS - CURRENT STATE OF KNOWLEDGE

      Drugs & aging
    37. CAMPBELL RWF
      INTERPRETATION OF THE RESULTS OF THE ELECTROPHYSIOLOGIC STUDY VERSUS ELECTROCARDIOGRAPHIC MONITORING (ESVEM) STUDY - IMPACT ON ALGORITHM FOR DRUG SELECTION

      Coronary artery disease
    38. CAMPBELL RWF
      POST INFARCT HEART-FAILURE - WHAT TO DO IN ADDITION TO ACE-INHIBITION

      Cardiovascular drugs and therapy
    39. SCHWARTZ PJ; CAMM AJ; FRANGIN G; JANSE MJ; JULIAN DG; SIMON P
      DOES AMIODARONE REDUCE SUDDEN-DEATH AND CARDIAC MORTALITY AFTER MYOCARDIAL-INFARCTION

      European heart journal
    40. BURKART F
      VALUE AND RISK OF CLASS-I AND CLASS-III ANTIARRHYTHMIC DRUGS

      PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY
    41. GILMAN JK; JALAL S; NACCARELLI GV
      PREDICTING AND PREVENTING SUDDEN-DEATH FROM CARDIAC CAUSES

      Circulation
    42. CAMPBELL RWF
      ELECTROPHYSIOLOGICAL DISTURBANCES IN HEART-FAILURE

      British Heart Journal
    43. DJIAN J
      MANAGEMENT OF PATIENTS AT RISK OF SUDDEN CARDIAC DEATH - THE EXAMPLE OF AMIODARONE

      Archives des maladies du coeur et des vaisseaux
    44. CRUICKSHANK JM
      PHOSPHODIESTERASE-III INHIBITORS - LONG-TERM RISKS AND SHORT-TERM BENEFITS

      Cardiovascular drugs and therapy
    45. NORTHOVER BJ
      IMPACT ON SURVIVAL OF A DECADE OF CHANGE IN THE MANAGEMENT OF PATIENTS WHO HAVE SUSTAINED A MYOCARDIAL-INFARCTION

      Cardiology
    46. ZAREMBSKI DG; NOLAN PE; SLACK MK; CARUSO AC
      EMPIRIC LONG-TERM AMIODARONE PROPHYLAXIS FOLLOWING MYOCARDIAL-INFARCTION - A METAANALYSIS

      Archives of internal medicine


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 04/08/20 alle ore 09:40:23